ALS (motor neurone disease): open trials in Poland

• NCT07322003

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

  Trial Treatment · Phase 3 · Prilenia

  Centrum Medyczne NEUROMED, Bydgoszcz · Linden sp. z o.o. sp. k., Krakow · City Clinic Research Sp. z o.o., Warsaw

  Registry updated 2026-10-27

• NCT07023835

  Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

  Trial Treatment · Phase 2 · Zydus Therapeutics Inc.

  Linden Sp. z o.o. sp.k., Cracow · Centrum Medyczne NeuroProtect, Warsaw

  Registry updated 2026-09-01

• NCT07142291

  PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

  Trial Treatment · Phase 2 · PhenoNet, Inc.

  SP ZOZ Szpital Uniwersytecki w Krakowie, Krakow · Michalski i Partnerzy Lekarze Spółka Partnerska, Krakow · Centrum Medyczne NeuroProtect (NeuroProtect Medical Center), Warsaw · City Clinic Research, Warsaw

  Registry updated 2026-07-23

• 2025-524002-16-00

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)

  Trial Treatment · Phase 3 · Ferrer Internacional S.A.

  Centrum Medyczne Neuromed Sp. z.o.o., Bydgoszcz · Linden Sp. z o.o. sp.k., Cracow · City Clinic Research Sp. z o.o., Warsaw

  Registry updated 2026-05-14

• NCT06841341

  Electrophysiology and Ultrasound of Respiratory Muscles and Respective Nerves to Predict Respiratory Insufficiency in ALS

  Research · Jagiellonian University

  Jagiellonian University Medical College, Department of Neurology, Krakow

  Registry updated 2025-09-15

• NCT03127267

  Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

  Trial Treatment · Phase 3 · AB Science

  Centrum Medyczne NEUROMED, Bydgoszcz

  Registry updated 2025-09-12

All ALS (motor neurone disease) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error